LAUSR

N 25 22 3 ASA 3.44 (0.51) 3.4 (0.5) 3.3 (0.6) ASA 3 14 (56.0) 12 (54.5) 2 (66.7) ASA 4 11 (44.0) 10 (45.5) 1 (33.3) Comorbidities Sleep apnea 1 (4.2) 0 (0.0) 1 (33.3) Pulmonary hypertension 0 (0.0) 0 (0.0) 0 (0.0) Prior MI 4 (16.0) 3 (13.6) 1 (33.3) Thyroid disease 1 (4.0) 1 (4.5) 0 (0.0) Hypertension 23 (92.0) 20 (90.9) 3 (100.0) Congestive heart failure 5 (20.0) 4 (18.2) 1 (33.3) COPD 3 (12.0) 2 (9.1) 1 (33.3) Diabetes mellitus 12 (48.0) 9 (40.9) 3 (100.0) Coronary artery disease 24 (96.0) 21 (95.5) 3 (100.0) Aortic valve disease 6 (24.0) 6 (27.3) 0 (0.0) Preoperative medications Beta blockers 17 (68.0) 16 (72.7) 1 (33.3) Calcium channel blockers 9 (36.0) 8 (36.4) 1 (33.3) Statins 21 (84.0) 20 (90.0) 1 (33.3) NSAIDS 18 (72.0) 17 (77.3) 1 (33.3) ACE inhibitors 16 (64.0) 13 (59.1) 3 (100.0) Benzodiazepines 2 (8.0) 1 (4.5) 1 (33.3) Opioids 3 (12.0) 3 (13.6) 0 (0.0) Amiodarone 1 (4.0) 1 (4.5) 0 (0.0) ARB 0 (0.0) 0 (0.0) 0 (0.0) Procedure AVR 3 (12.0) 3 (13.6) 0 (0.0) CABG 20 (80.0) 17 (77.3) 3 (100.0) CABG/AVR 2 (8.0) 2 (9.1) 0 (0.0) Time to Perform SGB (min) 2.4 (1.4) 2.4 (1.4) 2.7 (1.5)